The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales

Jon Paul Meyer; Rajendra Persad; John L. Probert; David A. Gillat

doi:10.1080/1561095021000005375

The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales

Jon Paul Meyer^*, Rajendra Persad, John L. Probert, David A. Gillat

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG "failures" also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.

Original language	English
Pages (from-to)	77-80
Number of pages	4
Journal	UroOncology
Volume	2
Issue number	2
DOIs	https://doi.org/10.1080/1561095021000005375
Publication status	Published - Jun 2002
Externally published	Yes

Keywords

Bacille Calmette-Guerin
Carcinoma-in-situ
Consultant urologists
Questionnaire
Transitional cell carcinoma

Access to Document

10.1080/1561095021000005375

Cite this

@article{c16d50dd95264e8bb7ce468a6efd7c16,

title = "The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales",

abstract = "Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG {"}failures{"} also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.",

keywords = "Bacille Calmette-Guerin, Carcinoma-in-situ, Consultant urologists, Questionnaire, Transitional cell carcinoma",

author = "Meyer, {Jon Paul} and Rajendra Persad and Probert, {John L.} and Gillat, {David A.}",

year = "2002",

month = jun,

doi = "10.1080/1561095021000005375",

language = "English",

volume = "2",

pages = "77--80",

journal = "UroOncology",

issn = "1561-0950",

publisher = "Taylor & Francis",

number = "2",

}

TY - JOUR

T1 - The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales

AU - Meyer, Jon Paul

AU - Persad, Rajendra

AU - Probert, John L.

AU - Gillat, David A.

PY - 2002/6

Y1 - 2002/6

N2 - Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG "failures" also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.

AB - Objective: To assess consultant practices and attitudes concerning the use of intravesical BCG for CIS, and high grade superficial TCC bladder in England and Wales. Materials and methods: Consultants in England and Wales, identified from the BAUS members handbook were sent a questionnaire survey to determine their usage of BCG and the reasons why they adopted their chosen practice. Results: Three hundred and sixteen completed questionnaires were returned, giving a response rate for the questionnaire of 70%. Although, the vast majority adopted a regimen of a weekly instillation of BCG for 6 weeks for an initial treatment course, the practice of maintenance therapy varied nationally. In addition to this, initial follow up of BCG patients, and how to manage the BCG "failures" also differed amongst consultant urologists in England and Wales. Conclusions: In patients receiving BCG, a consensus view should be sought to determine optimal management.

KW - Bacille Calmette-Guerin

KW - Carcinoma-in-situ

KW - Consultant urologists

KW - Questionnaire

KW - Transitional cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036625852&partnerID=8YFLogxK

U2 - 10.1080/1561095021000005375

DO - 10.1080/1561095021000005375

M3 - Article

AN - SCOPUS:0036625852

SN - 1561-0950

VL - 2

SP - 77

EP - 80

JO - UroOncology

JF - UroOncology

IS - 2

ER -

The treatment of high grade superficial bladder cancer and carcinoma in situ with BCG - A questionnaire survey of consultant practice in England and Wales

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this